Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis.
BACKGROUND Patients undergoing percutaneous coronary intervention (PCI) have a high cardiovascular risk. Current guidelines recommend a ≥50% low-density lipoprotein cholesterol (LDL-C) reduction from baseline. Notably, the recently published 2026 American College of Cardiology/American Heart Association/Multisociety Dy...